Contrary to FABP5’s role as tumor promoter in some types of cancer, such as cervical cancer or hepatocellular carcinoma [74], and as a malignancy element in adult LGG via NF-κB pathway activation [86], in the pHGG dataset studied, higher FABP5 expression was associated with a better prognosis (Figure 2C), pointing out the specific molecular pattern followed by pediatric CNS tumors. Here, FABP5 is linked to hepatocellular carcinoma.